share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Draghia-Akli Ruxandra

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Draghia-Akli Ruxandra

諾瓦瓦克斯醫藥 | 4:持股變動聲明-高管 Draghia-Akli Ruxandra
美股SEC公告 ·  11/14 05:15

Moomoo AI 已提取核心訊息

Novavax Inc. (NVAX) reported a transaction involving Ruxandra Draghia-Akli, a person with a Section 16 relationship to the issuer, according to a recent filing. The transaction occurred on 11/11/2024. However, the filing did not disclose specific details such as the action type, status, number of shares, nature of shares, transaction price, or the total value of shares involved. The number of shares held by Draghia-Akli after the action was also not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.
Novavax Inc. (NVAX) reported a transaction involving Ruxandra Draghia-Akli, a person with a Section 16 relationship to the issuer, according to a recent filing. The transaction occurred on 11/11/2024. However, the filing did not disclose specific details such as the action type, status, number of shares, nature of shares, transaction price, or the total value of shares involved. The number of shares held by Draghia-Akli after the action was also not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.
根據最近的公告,Novavax Inc. (NVAX)報告了一項涉及Ruxandra Draghia-Akli的交易,她與發行人有第16條關係。該交易發生在2024年11月11日。然而,公告中並未披露具體細節,如行動類型、狀態、股份數量、股份性質、交易價格或涉及的股份總價值。Draghia-Akli在行動後持有的股份數量也沒有提供。投資者被建議等待進一步細節,以全面評估該交易對其投資決策的影響。
根據最近的公告,Novavax Inc. (NVAX)報告了一項涉及Ruxandra Draghia-Akli的交易,她與發行人有第16條關係。該交易發生在2024年11月11日。然而,公告中並未披露具體細節,如行動類型、狀態、股份數量、股份性質、交易價格或涉及的股份總價值。Draghia-Akli在行動後持有的股份數量也沒有提供。投資者被建議等待進一步細節,以全面評估該交易對其投資決策的影響。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息